Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Bone marrow transplantation for erythroleukemia: a case report

K Kogawa1, I Sekine, T Masuda

  • 1Department of Pediatrics, National Defense Medical College, Saitama, Japan.

Acta Paediatrica Japonica : Overseas Edition
|December 1, 1994
PubMed
Summary

Erythroleukemia (EL) in a child achieved remission with low-dose cytosine arabinoside (Ara-C) followed by successful allogeneic bone marrow transplantation. This approach offers durable engraftment and remission, suggesting BMT as a viable option for pediatric EL.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Diagnosis and treatment of bone metastasis: comprehensive guideline of the Japanese Society of Medical Oncology, Japanese Orthopedic Association, Japanese Urological Association, and Japanese Society for Radiation Oncology.

ESMO open·2016
Same author

Expression of p53 synergistically augments caspases-mediated apoptosis induced by replication-competent adenoviruses in pancreatic carcinoma cells.

Cancer gene therapy·2015
Same author

Zoledronic acid induces apoptosis and S-phase arrest in mesothelioma through inhibiting Rab family proteins and topoisomerase II actions.

Cell death & disease·2014
Same author

Maintenance of the hematopoietic stem cell pool in bone marrow niches by EVI1-regulated GPR56.

Leukemia·2013
Same author

Quantitation of human herpesvirus-6 (HHV-6) DNA in a cord blood transplant recipient with chromosomal integration of HHV-6.

Transplant infectious disease : an official journal of the Transplantation Society·2011
Same author

Does smoking or family history influence the prognosis of patients with non-small cell lung cancer?

Oncology reports·2011

Area of Science:

  • Hematology
  • Pediatric Oncology
  • Hematopoietic Stem Cell Transplantation

Background:

  • Erythroleukemia (EL), classified as M6 by the French-American-British system, is a rare and aggressive subtype of acute myeloid leukemia.
  • Conventional chemotherapy regimens have shown limited success in achieving long-term disease-free survival for children diagnosed with EL.

Observation:

  • A 2-year-old girl with erythroleukemia achieved complete remission after a single course of low-dose cytosine arabinoside (Ara-C).
  • Following consolidation therapy with three courses of low-dose Ara-C, the patient underwent allogeneic bone marrow transplantation (BMT) from an HLA-identical sibling.

Findings:

  • The post-transplantation period was uneventful, with the patient demonstrating durable engraftment and sustained remission two years after BMT.

Related Experiment Videos

  • This case highlights the potential efficacy of combining chemotherapy with allogeneic BMT in managing pediatric erythroleukemia.

    • Implications:

    • Allogeneic bone marrow transplantation should be strongly considered as a therapeutic option for children with erythroleukemia, particularly when a suitable donor is available.
    • This case underscores the limitations of conventional chemotherapy for achieving long-term outcomes in pediatric EL and supports BMT as a potentially curative strategy.